Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxil-CR in Fibromyalgia Syndrome
NCT00610610Phase 4Completed
- Sponsor
- Duke University
- Start
- Jan 2002
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paroxetine in fibromyalgia syndrome (FMS), sponsored by Duke University. Started Jan 2002; status: completed.
02
Drugs
paroxetine
03
Conditions
fibromyalgia syndrome (FMS)
Beyond the preview
Go deeper on NCT00610610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610610.